EP2170064A4 - 6,5-pyrrolopiperidine tachykinin receptor antagonists - Google Patents

6,5-pyrrolopiperidine tachykinin receptor antagonists

Info

Publication number
EP2170064A4
EP2170064A4 EP08771300A EP08771300A EP2170064A4 EP 2170064 A4 EP2170064 A4 EP 2170064A4 EP 08771300 A EP08771300 A EP 08771300A EP 08771300 A EP08771300 A EP 08771300A EP 2170064 A4 EP2170064 A4 EP 2170064A4
Authority
EP
European Patent Office
Prior art keywords
pyrrolopiperidine
receptor antagonists
tachykinin receptor
tachykinin
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08771300A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2170064A1 (en
Inventor
Jianming Bao
Robert J Devita
Huagang Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck Sharp and Dohme LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme LLC filed Critical Merck Sharp and Dohme LLC
Publication of EP2170064A1 publication Critical patent/EP2170064A1/en
Publication of EP2170064A4 publication Critical patent/EP2170064A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP08771300A 2007-06-22 2008-06-18 6,5-pyrrolopiperidine tachykinin receptor antagonists Withdrawn EP2170064A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93686407P 2007-06-22 2007-06-22
PCT/US2008/067270 WO2009002770A1 (en) 2007-06-22 2008-06-18 6.5-pyrrolopiperidine tachykinin receptor antagonists

Publications (2)

Publication Number Publication Date
EP2170064A1 EP2170064A1 (en) 2010-04-07
EP2170064A4 true EP2170064A4 (en) 2010-08-04

Family

ID=40185984

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08771300A Withdrawn EP2170064A4 (en) 2007-06-22 2008-06-18 6,5-pyrrolopiperidine tachykinin receptor antagonists

Country Status (5)

Country Link
EP (1) EP2170064A4 (ja)
JP (1) JP2010530874A (ja)
AU (1) AU2008268667A1 (ja)
CA (1) CA2690737A1 (ja)
WO (1) WO2009002770A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101074202B1 (ko) * 2007-01-18 2011-10-14 에스케이종합화학 주식회사 에틸렌 사량체화 촉매계 및 이를 이용한 1-옥텐의 제조방법
RS56634B1 (sr) 2009-11-20 2018-03-30 Tonix Pharma Holdings Ltd Postupci i kompozicije za lečenje simptoma povezanih sa posttraumatskim stresnim poremećajem korišćenjem ciklobenzaprina
US20110319389A1 (en) 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US11998516B2 (en) 2011-03-07 2024-06-04 Tonix Pharma Holdings Limited Methods and compositions for treating depression using cyclobenzaprine
ES2672099T3 (es) 2011-07-04 2018-06-12 Irbm - Science Park S.P.A. Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal
RU2631319C2 (ru) 2012-02-22 2017-09-21 Лео Фарма А/С Новые соединения - антагонисты рецептора нейрокинина 1
AR092211A1 (es) * 2012-09-24 2015-04-08 Merck Patent Ges Mit Beschränkter Haftung Derivados de hidropirrolopirrol
ES2769879T3 (es) 2013-03-15 2020-06-29 Tonix Pharma Holdings Ltd Formulaciones eutécticas de clorhidrato de ciclobenzaprina y manitol
WO2015024203A1 (en) * 2013-08-20 2015-02-26 Leo Pharma A/S Novel neurokinin 1 receptor antagonist compounds ii
CN105579456A (zh) * 2013-08-20 2016-05-11 利奥制药有限公司 新型神经激肽1受体拮抗剂化合物ii
CA2961822A1 (en) 2014-09-18 2016-03-24 Tonix Pharma Holdings Limited Eutectic formulations of cyclobenzaprine hydrochloride
BR112020011345A2 (pt) 2017-12-11 2020-11-17 Tonix Pharma Holdings Limited tratamento com ciclobenzaprina para agitação, psicose e declínio cognitivo na demência e condições neurodegenerativas
AU2019223237A1 (en) 2018-02-26 2020-09-03 Ospedale San Raffaele S.R.L. NK-1 antagonists for use in the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110996A1 (en) * 2003-06-19 2004-12-23 Pfizer Products Inc. Nk1 antagonist

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203020D0 (en) * 2002-02-08 2002-03-27 Glaxo Group Ltd Chemical compounds
AU2005316676A1 (en) * 2004-12-14 2006-06-22 Merck & Co., Inc. Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004110996A1 (en) * 2003-06-19 2004-12-23 Pfizer Products Inc. Nk1 antagonist

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009002770A1 *

Also Published As

Publication number Publication date
JP2010530874A (ja) 2010-09-16
AU2008268667A1 (en) 2008-12-31
WO2009002770A1 (en) 2008-12-31
EP2170064A1 (en) 2010-04-07
CA2690737A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
EP2170064A4 (en) 6,5-pyrrolopiperidine tachykinin receptor antagonists
TWI341198B (en) Hydroisoindoline tachykinin receptor antagonists
SI2094690T1 (sl) Derivati 2-aza-biciklo(3.1.0)heksana kot antagonisti receptorja za oreksin
HRP20151108T1 (en) Nogo receptor antagonists
EP2099454A4 (en) AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS
EP2349269A4 (en) 2,5-DISUBSTITUTED PIPERIDINOREXINE RECEPTOR ANTAGONISTS
EP2350066A4 (en) 2,5-DISUBSTITUTED PIPERIDINES AS ANTAGONISTS OF THE OREXIN RECEPTOR
AP2403A (en) Histamine-3 receptor antagonists.
EP2058304A4 (en) P2X4 RECEPTOR ANTAGONIST
EP2350061A4 (en) 2,3-DISUBSTITUTED PIPERIDINOREXINE RECEPTOR ANTAGONISTS
IL192426A0 (en) Prokineticin 2 receptor antagonists
EP1871752A4 (en) ANTAGONISTS OF THE AMIDOPROPOXYPHENYLOREXIN RECEPTOR
EP2349270A4 (en) 2,5-DISUBSTITUTED MORPHOLINE OREXIN RECEPTOR ANTAGONISTS
EP2184278A4 (en) P2X4 RECEIVER ANTAGONIST
IL192424A0 (en) Prokineticin 1 receptor antagonists
IL187424A0 (en) C5a RECEPTOR ANTAGONISTS
SI2001876T1 (sl) 8-azabiciklo(3.2.1)oktanske spojine kot antagonisti mu-opioidnega receptorja
IL190686A0 (en) Il-21 receptor antagonists
IL184278A0 (en) C5a RECEPTOR ANTAGONISTS
IL201165A0 (en) CRIg ANTAGONISTS
IL195807A0 (en) Cgrp receptor antagonists
EP1898905A4 (en) ANTAGONISTS OF TACHYKININ HYDRO-ISO-INDOLIC RECEPTORS
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
EP1976527A4 (en) CONDENSED TRIAZOL TACHYKININE RECEPTOR ANTAGONISTS
IL207700A0 (en) 3-aminoalkyl-1,4-diazepan-2-one melanocortin -5 receptor antagonists

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20100707

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 25/24 20060101ALI20100701BHEP

Ipc: A61P 25/22 20060101ALI20100701BHEP

Ipc: A61P 25/06 20060101ALI20100701BHEP

Ipc: A61P 13/00 20060101ALI20100701BHEP

Ipc: A61K 31/437 20060101ALI20100701BHEP

Ipc: C07D 471/04 20060101AFI20100701BHEP

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110207